title: Serum concentrations of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosis.
abstract: OBJECTIVE
  Insulin-like growth factor-I is an important anabolic polypeptide with various effects. The circulating insulin-like growth factor-I is mainly liver derived. The aim of this study was to determine insulin-like growth factor-I serum levels in patients with cirrhosis and to clarify their association with patients' clinical condition and the etiology of cirrhosis.
  
  
  METHODS
  Forty patients with liver cirrhosis were enrolled. Cirrhosis was in 22 cases induced by virus, in 10 due to primary biliary cause and in the rest 8 of alcoholic origin. The Child score index was found as A (n = 26), B (n = 9), C (n = 5). Twenty, age-matched healthy subjects, were used as a control group. Serum insulin-like growth factor-I was measured by an immunoradiometric assay in all subjects.
  
  
  RESULTS
  Serum insulin-like growth factor-I levels in liver cirrhosis were found very significantly lower than in healthy individuals (57.4 +/- 7.0 ng/mL vs. 198.8 +/- 16.3 ng/mL, p = 0.0000001). In liver cirrhosis insulin-like growth factor-I was negatively correlated with spleen enlargement (r = -0.46, p = 0.0031). Child B and C patients showed significantly reduced insulin-like growth factor-I levels in comparison to patients staged as Child A (28.9 +/- 3.0 ng/mL vs. 72.8 +/- 9.3 ng/mL, p = 0.0016). The comparison of 12 patients with viral induced cirrhosis (Child A) to 14 patients with non-viral cirrhosis, of the same clinical stage, showed non-significant difference (84.2 +/- 16 ng/mL vs. 63.1 +/- 10.3 ng/mL, p = 0.27).
  
  
  CONCLUSIONS
  Insulin-like growth factor-I synthesis is disturbed in liver cirrhosis and reflects the severity of the clinical stage. It represents a good marker of hepatic function. The etiology of cirrhosis does not seem to influence its levels.
authors.affiliation: Second Propedeutic Department of Internal Medicine, Aristotelion University of Thessaloniki, Greece. avyz@med.auth.gr
authors.forename: T
authors.initials: T
authors.lastname: Vyzantiadis
authors.forename: S
authors.initials: S
authors.lastname: Theodoridou
authors.forename: O
authors.initials: O
authors.lastname: Giouleme
authors.forename: P
authors.initials: P
authors.lastname: Harsoulis
authors.forename: N
authors.initials: N
authors.lastname: Evgenidis
authors.forename: A
authors.initials: A
authors.lastname: Vyzantiadis
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D015592:Immunoradiometric Assay; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008099:Liver / Q000503:physiopathology; D008103:Liver Cirrhosis / Q000097:blood* / Q000175:diagnosis / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012016:Reference Values
chemical_list: D007334:Insulin-Like Growth Factor I